Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

Douglas B. Johnson, Justin M. Balko, Ann Richmond et al.|Nature Communications|2016

Cited by 572